News Channels

22 Aug 2017 PharmAkea Announces Successful Completion of a Phase 1 Trial in Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251
22 Aug 2017 Teikoku Pharma USA Announces Positive Topline Results from Phase 2 Clinical Trial of TPU-006, Non‑Opioid Pain Management Patch in Bunionectomy Surgery
22 Aug 2017 ViraCyte Announces Positive Phase 2 Trial Results
22 Aug 2017 Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers
22 Aug 2017 Cellerant Therapeutics, Inc. Awarded $6.86 Million Grant From California Institute for Regenerative Medicine to Support Development of Novel Antibody-Drug Conjugate for AML
22 Aug 2017 Grid Therapeutics Signs Exclusive License Agreement to Develop a Novel Immuno-Oncology Antibody
22 Aug 2017 Apic Bio Launches to Advance First-in-Class Gene Therapy for Treatment of Alpha-1 Antitrypsin Deficiency (Alpha 1)
22 Aug 2017 Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune tolerance
22 Aug 2017 Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
22 Aug 2017 CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
22 Aug 2017 Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
22 Aug 2017 First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteritinib as Maintenance Therapy Following Hematopoietic Stem Cell Transplant in Patients with FLT3 Mutation-positive Acute Myeloid Leukemia
22 Aug 2017 Takeda Submits a New Drug Application for Vedolizumab for the Treatment of Moderately to Severely Ulcerative Colitis in Japan
22 Aug 2017 Cardiome provides U.S. regulatory update for brinavess
21 Aug 2017 Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder
21 Aug 2017 Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
21 Aug 2017 MatriSys Bioscience, Inc. Announces First Patient Dosed in Phase 2A Clinical Trial with Live Staphylococcus hominis Bacteria for the Treatment of Atopic Dermatitis
21 Aug 2017 Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
21 Aug 2017 Ovid Therapeutics Announces First Patient Randomized in Phase 1b/2a Clinical Trial of TAK-935/OV935 in Adults with Rare Epilepsies
21 Aug 2017 New XARELTO® (rivaroxaban) Data at ESC Congress 2017 Includes Late-Breaking Results from Landmark Phase 3 COMPASS Study

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top